Aller au contenu principal
Accès ouvert déclaré 2023 preprint

Effectiveness of High-resolution T2-weighted Mri in Restaging Rectal Cancer After Neoadjuvan Chemoradiotherapy

0Citations signalées, ce qui n’est pas une note de qualité
1Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : co. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Abstract Objective: The technical success of high-resolution T2-weighted magnetic resonance imaging (hT2W-MRI) sequence in restaging locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy (nCRT) was investigated. Materials and methods: Nineteen patients with an age mean 56 ( range of 37-76) who received nCRT for rectal cancer, had MRI for the rectum and underwent surgical operation between 2020-2022 were included in the study. MRI results were compared with relevant histopathological studies after definitive surgery . Results: hT2W-MRI correctly predicted all tumors with pathological stage T3 100% (5/5). hT2W-MRI predicted correctly in 3 of 4 patients with pathological stages T4a and T4b (75%). Considering lymph node positivity, the prediction rate of hT2W-MRI was 42.1%(8/19). hT2A-MRI correctly predicted all tumors with circumferential resection margin (CRM), peritoneal reflection involvement, and extramural venous invasion (EMVI). The success of hT2W-MRI in predicting the pathological response (residual tumor) was high (89.5%, 17/19). Conclusion: Staging of rectal cancer after nCRT is important for treatment planning. Functional assessment with diffusion-weighted MRI and perfusion MRI play a role in predicting tumor aggressiveness, likelihood of response to treatment, and size of tumor remaining after treatment. An accurate and practical radiological identification is important, as the findings on MRI after nCRT are related to the patient's prognosis and survival, and the tumor stage is based on the depth of invasion of the rectal wall and the involvement of adjacent organs. It would be beneficial to include the hT2A-MRI sequence in standard pelvic MRI examination sequences in staging of rectal cancer after nCRT and in demonstrating the presence of residual tumor.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Effectiveness of High-resolution T2-weighted Mri in Restaging Rectal Cancer After Neoadjuvan Chemoradiotherapy
Date Crossref
19/08/2023
Éditeur
Research Square Platform LLC
Type
posted-content

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Colorectal Cancer Surgical TreatmentsRadiomics and Machine Learning in Medical ImagingColorectal and Anal Carcinomas

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.